Burger Menu

Site built by UNOMENA

Site built by UNOMENA

quibim-img-for-profile.png
QUIBIM is a medtech specializing in the extraction of standardised, quantitative information from medical imaging data sets using artificial intelligence (AI). QUIBIM’s medical image postprocessing and extraction of imaging biomarkers enables hospitals and pharmaceutical companies to detect diseases early and systematically. 

QUIBIM has already launched more than 20 algorithms for a range of conditions including cancer, Alzheimer’s, osteoarthritis and liver disease. It has recently launched chest X-ray and CT scan products for COVID-19. Its products are used in over 70 hospitals and 11 clinical trials across the world, with 600,000 analyses and 6.5 million images processed to date.

In July 2020, the company announced that it has closed €8M in new financing in a seed funding round co-led by Amadeus Capital Partners and Adara Ventures, with participation by Apex Ventures, Partech, Crista Galli Ventures and existing shareholders, including Tech Transfer UPV, managed by Clave Capital and Juan Roig.  


About the founders/CEO:

QUIBIM was founded by Dr. Ángel Alberich-Bayarri and Prof. Luis Marti-Bonmati, two innovators at the forefront of medical imaging. They established the process for the development of biomarkers, adopted in 2013 by the European Society of Radiology (ESR) as the official industry standard. They again set a benchmark when, in March 2020, QUIBIM became the main AI platform for screening for COVID-19 across Europe. Shortly after, the Radiological Society of North America (RSNA), with more than 52,000 members from 153 countries, joined the initiative with the goal of creating a global medical repository of COVID-19 cases, with the European arm running on QUIBIM Precision®. 

Before founding QUIBIM, Dr. Ángel Alberich-Bayarri worked first as a telecom engineer for the University of Valencia and then for various R&D projects, for two hospitals and for SEDIA Investiga. He also worked for the Grupo Universitario Quiron in R&D. Dr. Ángel Alberich-Bayarri holds a PhD in Engineering and Biomedical Engineering one in from the Universitat Politècnica de València. He is QUIBIM's CEO.

< Back Home